Utilizziamo i cookie per rendere il nostro sito più facile ed intuitivo. I dati raccolti grazie ai cookie servono per rendere l'esperienza di navigazione più piacevole e più efficiente in futuro.

Soci Sostenitori

Scopri le principali aziende operanti nel Controllo della Contaminazione Ambientale che supportano le attività di ASCCA...

Leggi tutto...

ASCCA News

La rivista che offre al lettore articoli tecnici, case history e rubriche tecnico-commerciali sui fenomeni della contaminazione ambientale...

Leggi tutto...

Seminari ON AIR

Scoprite l'elenco dei seminari on-air proposti per il 2020 da ASCCA, la nuova iniziativa per continuare la propria attività divulgativa.

Leggi tutto...

Formazione professionale

Scopri i corsi di formazione per operatori in clean room organizzati dal Politecnico di Milano con il patrocinio di ASCCA...

Leggi tutto...



JOINT WEBINAR ASCCA-ISPE-PDA

immagine copertina

BIOTECH AND ADVANCED THERAPIES AT A GLANCE
24 - 25 - 26 NOVEMBER 2020
ZOOM PLATFORM 

The new borders of Biotech Therapy from the most innovative vaccines to the advanced therapies: innovation and research for a new generation of medicines

logo completo 2019

ASCCA SEMINAR - Advanced Therapies: new technological and regulatory challenges
24 November 2020 - Time 2.00 pm - 5.30 pm (CEST)
Speakers: S. Guidi (Rigenerand) - J.F. Brunet (Lausanne Unversity Hospital) - L. Mariotta (Swiss Stem Cells Biotech SA)
Chair: Marco Fadda (Comecer)

The advanced therapies represent now the future of the pharmaceutical and biological research.Through the experience of the involved companies and actors we will review the technological solutions implemented by who is working actively on this field

  • cGMP manufacturing of cell-based medicinal products: challenges and solutions
    Simona Guidi (Business Development Director Rigenerand)

  • Cell manufacturing facility at Lausanne University Hospital, GMP rules into a public institution: we do it
    Jean Francois Brunet (Cell Production Center - Service of Pharmacy - Lausanne University Hospital)

  • A private laboratory to the production of Advanced Therapies coordinated with Cord Blood Bank: challenges and opportunities
    Luca Mariotta (Plant Manager - Swiss Stem Cells Biotech SA)

  • Final discussions, Q&A

Logoispe

ISPE Seminar - The Automation and digital era of Biotech Manufacturing
25 November 2020 – Time 2.00 pm - 5.30 pm (CEST)
Speakers: M. Magni, F. Stoppa (Jacobs Italia) - B. Kiss (Gedeon Richter Plc) - M. Mangiarotti (Takeda) - G. Orlandi (Wood Lifesciences)
Chair: Matteo Valle (Air Liquide)

High capacity levels, high safety standards and production flexibility have a crucial role in the production of Biotech medicines.Technology can support in meeting these requirements through the use of Single Use Technology and the possibility of a customized manufacturing. The case studies presented in this session will give us practical examples

  • Single Use Technology vs stainless steel within biotech facilities and relevant study through a process simulation tool
    Marco Magni (Manager of Biotech  - Jacobs Italia) - Fabiana Stoppa (Senior Biotech Process Engineer  - Jacobs Italia)

  • Dedicated vs. multi-product biotech facility: GMP and operational issues from an User standpoint 
    Balázs Kiss (Plant manager  - Biotechnological Production Plant Debrecen - Gedeon Richter Plc.)

  • Opportunities for modern robotics in biopharma manufacturing 
    Maurizio Mangiarotti (Takeda) - Giampaolo Orlandi  - Simon Miles (Wood Lifesciences)

  • Final discussions, Q&A

PDA 

PDA Seminar - Quality challenges in Biotech Manufacturing
26 November 2020 – Time 2.00 pm - 5.30 pm
Speakers: F. Micoli (GSK Vaccines) - S. Cianetti (GSK Vaccines Institute) - C. Paolella (BSP Pharmaceutcials)
Chair: Cristina Campa (GSK Vaccines Institute)

The vaccines and conjugated medicines manufacturing are currently one of the hottest topics in pharmaceutical world. Quality aspects have a crucial role in the production of effective and safe drugs and high-level standards are mandatory in the production of this type of medicines. The case studies presented in this session will give us practical examples of quality requirements in Biotech manufacturing

  • Vaccine platforms: the GMMA case study
    Francesca Micoli (GSK Vaccines Institute)

  • Comparability in development and lifecycle of biological products
    Simona Cianetti (Technical R&D GSK Vaccines)

  • Development and optimization of a conjugation process: manufacturing and quality
    Concetta Paolella (BSP Pharmaceuticals)

  • Final discussions, Q&A

ON LINE REGISTRATION  

FREE REGISTRATION - Click HERE

OFFICIAL LANGUAGE

The official language is English

PROGRAMME 

Download the full programme

SPONSORSHIP  

Interested in sponsoring the event? Download the sponsorship form and contact us for more info:  marta.daffara@pragmacongressi.it